AKT1 and metabolic dysfunction-associated steatotic liver disease: KEGG pathway enrichment analysis revealed that LF influences the MAPK, PI3K‐Akt, and FoxO signaling pathway, contributing to its therapeutic effects on NAFLD and DM comorbidity.